Percorrer por autor "Doumett, Saer"
A mostrar 1 - 4 de 4
Resultados por página
Opções de ordenação
- Development of highly hydrophilic yolk-shell Fe3O4@C magnetic nanoparticles: a potential tool for the theranostics of cancerPublication . Rodrigues, Raquel Oliveira; Doumett, Saer; Baldi, Giovanni; Bañobre-López, Manuel; Gallo, Juan; Lima, Rui A.; Silva, Adrián; Gomes, HelderDue to their remarkable physicochemical properties acquired at the nanoscale, magnetic nanoparticles (MNPs) are of interest in several disciplines, such as data storage, water purification, biochips and biomedicine (1). In order to prevent the oxidation of the MNPs, and their aggregation, several procedures have been developed to encapsulate them as a magnetic core (2). In particular, carboncoated nanoparticles have several advantages in comparison to polymer or silica coatings, since they usually offer higher chemical and thermal stability, large surface area, biocompatibility and easier functionalization (1, 3). These properties are especially important for biomedical applications, where MNPs should be chemically-functionalized with specific biocompatible targeting molecules to allow their selective attachment to cells or tissues.
- Development of stimuli-responsive graphene-based yolk-shell magnetic nanoparticles for controlled release of anticancer drugsPublication . Rodrigues, Raquel Oliveira; Baldi, Giovanni; Doumett, Saer; Bañobre-López, Manuel; Gallo, Juan; Dražić, Goran; Lima, Rui A.; Silva, Adrián; Gomes, HelderMagnetic drug delivery systems have attracted much attention in the last decades due to the possibility to improve the therapeutic efficacy of anticancer drugs, by enabling instable and poorly soluble drug agents to reach tumour cells after being guided by low magnetic fields and monitored by magnetic resonance imaging (MRI) [1]. Hence, a lower amount of anticancer drug is needed and the typical side effects of chemotherapy are minimized [2]. Commonly, these nanoparticles are designed with a magnetic core coated with a metal or a non-metal structure, such as gold or silica. However, these approaches present some drawbacks, such as low drug loading capacity and lack of stimuli-responsive release. Alternatively, carbon-coated magnetic nanoparticles offer higher chemical and thermal stability, larger surface area, biocompatibility and easier functionalization due to the high capacity of adsorption. Moreover, these materials have shown great ability to be used as pH stimuli-responsive controlled release platforms, due to the disruption of supramolecular interaction at acidic pH [3]. In this context, graphene-coated yolk-shell magnetic nanoparticles – hybrid materials comprising a superparamagnetic core coated by a graphene-based shell that covers a hollow region (i.e., Fe3O4@void@C), – were developed as super-drug nanocarriers systems, exhibiting high loading contents of the anticancer drug Doxorubicin due to the large cavity volume between the shell and the magnetic core, and a stimuliresponsive controlled release in response to acidic environments (pH 5), such as those found in tumour tissues. These results shed light on the development of new hybrid nanomaterials with high potential to be applied in biomedical applications.
- Multifunctional graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug deliveryPublication . Rodrigues, Raquel Oliveira; Baldi, Giovanni; Doumett, Saer; Garcia-Hevia, Lorena; Gallo, Juan; Bañobre-López, Manuel; Dražić, Goran; Calhelha, Ricardo C.; Ferreira, Isabel C.F.R.; Lima, Rui A.; Gomes, Helder; Silva, AdriánThe synthesis of hydrophilic graphene-based yolk-shell magnetic nanoparticles functionalized with copolymer pluronic F-127 (GYSMNP@PF127) is herein reported to achieve an efficient multifunctional biomedical system for mild hyperthermia and stimuli-responsive drug delivery. In vitro tests revealed the extraordinary ability of GYSMNP@PF127 to act as smart stimuli-responsive multifunctional nanomedicine platform for cancer therapy, exhibiting (i) an outstanding loading capacity of91% (w/w,representing 910μgmg−1) of the chemotherapeutic drug doxorubicin, (ii) a high heating efficiency under an alternating (AC) magnetic field (intrinsic power loss ranging from 2.1–2.7nHm2kg−1), and (iii) a dual pH and thermal stimuli-responsive drug controlled release (46% at acidic tumour pH vs 7% at physiological pH) under AC magnetic field, in just 30min. Additionally, GYSMNP@PF127 presents optimal hydrodynamic diameter (DH=180nm) with negative surface charge, high haemocompatibility for blood stream applications and tumour cellular uptake of drug nanocarriers. Due to its physicochemical, magnetic and biocompatibility properties, the developed graphene-based magnetic nanocarrier shows high promise as dual exogenous (AC field)/endogenous (pH) stimuli-responsive actuators for targeted thermo-chemotherapy, combining magnetic hyperthermia and controlled drug release triggered by the abnormal tumour environment. The presented strategy and findings can represent a new way to design and develop highly stable added-value graphene-based nanostructures for the combined treatment of cancer.
- A Tailor-made protocol to synthesize yolk-shell graphene-based magnetic nanoparticles for nanomedicinePublication . Rodrigues, Raquel Oliveira; Baldi, Giovanni; Doumett, Saer; Gallo, Juan; Bañobre-López, Manuel; Dražić, Goran; Calhelha, Ricardo C.; Ferreira, Isabel C.F.R.; Lima, Rui A.; Silva, Adrián; Gomes, HelderA simple tailor-made protocol to synthesize graphene-based magnetic nanoparticles (GbMNPs) for nanomedicine is herein reported. Different GbMNPs with very distinctive physicochemical and toxicological properties were synthesized by adjusting the number of carbon precursors in the coating of superparamagnetic iron oxide nanoparticles. In vitro tests show the ability to use these GbMNPs as intelligent and on-demand drug nanocarrier systems for drug delivery, exhibiting the following features: good colloidal stability, good loading capacity of the chemotherapeutic drug doxorubicin, high pH-controlled release of the encapsulated drug (targeting tumour acidic pH conditions), superparamagnetic behaviour and biocompatibility. Due to their combined properties (i.e., physicochemical, magnetic, and biocompatibility), GbMNPs show high potentiality to be combined with other biomedical techniques, such as magnetic hyperthermia, which can represent an enhancement in the treatment of cancer.